Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
ConclusionsPatients undergoing treatment with ICI or targeted therapies can safely undergo surgery without substantially increased risk of serious intraoperative and postoperative complications.
Source: World Journal of Surgery - Category: Surgery Source Type: research
More News: Academia | Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | Melanoma | Palliative | Skin Cancer | Surgery